Shares of Eton Pharmaceuticals Inc. (ETON) jumped about 11% in premarket trading on Wednesday after the company said its experimental treatment for alcohol poisoning is being reviewed by the Food and Drug Administration. The regulator is expected to make a decision whether to approve the injection on or by June 27. Eton's stock is down 25.6% over the past 12 months, while the broader S&P 500 has declined 16.1%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.